IP Verse

Oral Pharmaceutical Compositions Of Dabigatran Etexilate - EP2817000

The patent EP2817000 was granted to Esteve Pharmaceuticals on Aug 4, 2021. The application was originally filed on Feb 21, 2013 under application number EP13704974A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2817000

ESTEVE PHARMACEUTICALS
Application Number
EP13704974A
Filing Date
Feb 21, 2013
Status
Granted And Under Opposition
Jul 2, 2021
Publication Date
Aug 4, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMM & WITTKOPPMay 4, 2022HAMM & WITTKOPPADMISSIBLE
AERAMay 3, 2022AERAADMISSIBLE
AERAMay 3, 2022BARDEHLE PAGENBERG SLADMISSIBLE
GLENMARK PHARMACEUTICALS EUROPEApr 14, 2022SCHLICHWITHDRAWN

Patent Citations (30) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005038077
DESCRIPTIONUS2006074056
DESCRIPTIONUS2006183779
DESCRIPTIONWO2005028468
DESCRIPTIONWO9837075
EXAMINATIONUS2005123606
EXAMINATIONUS2006183779
EXAMINATIONUS2011129538
EXAMINATIONWO2012001156
INTERNATIONAL-SEARCH-REPORTUS2005038077
OPPOSITIONCN102793699
OPPOSITIONIN461MUM2012
OPPOSITIONUS2004109890
OPPOSITIONUS2005038077
OPPOSITIONUS2005123606
OPPOSITIONUS2006183779
OPPOSITIONUS2007184110
OPPOSITIONUS2011129538
OPPOSITIONWO03074056
OPPOSITIONWO2009118321
OPPOSITIONWO2009118322
OPPOSITIONWO2010007016
OPPOSITIONWO2012001156
OPPOSITIONWO2012162492
OPPOSITIONWO2013124340
OTHERUS2004109890
OTHERUS2005123606
OTHERUS2006183779
OTHERUS2011129538
OTHERWO2012001156

Non-Patent Literature (NPL) Citations (2) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- ANONYMOUS, "European Machine Agency. CHMP Assessement Report for Pradaxa. dabigratan etexil te.", (20080101), pages 1 - 36, URL: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000829/WC500041062.pdf, (20130801), XP003032104
OPPOSITION- "Handbook of Pharmaceutical Excipients Sixth Edition /Passage/", Rowe Raymond C, Paul J Sheskey; Marian E Quinn, Handbook of Pharmaceutical Excipients Sixth Edition, Pharmaceutical Press, (20090101), pages 129-133, 206-208, 317-322, 728 - 731, XP055923269

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents